Fasiglifam-induced liver injury in patients with type 2 diabetes: Results of a randomized controlled cardiovascular outcomes safety trial

the GRAND 306 Investigators

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Fasiglifam-induced liver injury in patients with type 2 diabetes: Results of a randomized controlled cardiovascular outcomes safety trial'. Together they form a unique fingerprint.

Medicine & Life Sciences